You have access
Role of Hematological Markers in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Treated With Pembrolizumab
KOHEI HAGIWARA, TAKASHI MATSUKI, TAKURO OKADA, CHIHIRO FUSHIMI, TAKAHITO KONDO, HIDEAKI TAKAHASHI, ISAKU OKAMOTO, KUNIHIKO TOKASHIKI, KENJI HANYU, TAKUMA KISHIDA, TATSUYA ITO, GAI YAMASHITA, KIYOAKI TSUKAHARA, TATSUO MASUBUCHI, YUICHIRO TADA, KAHO MOMIYAMA, RYOHEI YAGUCHI, NOBUHIKO ORIDATE, GO OMURA and TAKU YAMASHITA
Anticancer Research September 2024, 44 (9) 4057-4072; DOI: https://doi.org/10.21873/anticanres.17235